Key Documents

View All Documentation

GF62158596

Lithium

Name: Lithium
Brand: ALDRICH

foil, not light tested, 38x200mm, thickness 0.20mm, as rolled, 99.9%

Synonym(s):

Lithium, LI000220

Select a Size

Change View

About This Item

Linear Formula:

CAS Number:

7439-93-2

Molecular Weight:

6.94

NACRES:

NA.23

PubChem Substance ID:

329809388

UNSPSC Code:

12141803

MDL number:

MFCD00134051

Technical Service

Need help? Our team of experienced scientists is here for you.

Let Us Assist

Properties

assay

99.9%

form

foil

manufacturer/tradename

Goodfellow 621-585-96

resistivity

9.446 μΩ-cm, 20°C

size × thickness

38x200 mm × 0.20 mm

bp

1342 °C (lit.)

mp

180 °C (lit.)

density

0.534 g/mL at 25 °C (lit.)

SMILES string

[Li]

InChI

1S/Li

InChI key

WHXSMMKQMYFTQS-UHFFFAOYSA-N

Description

General description

For updated SDS information please visit www.goodfellow.com.

Legal Information

Product of Goodfellow

Still not finding the right product?

Explore all of our products under Lithium

Storage Class

4.3 - Hazardous materials which set free flammable gases upon contact with water

wgk

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable

Regulatory Information

新产品

This item has

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

The prevalence and management of side effects of lithium and anticonvulsants as mood stabilizers in bipolar disorder from a clinical perspective: a review.

Annemiek Dols et al.

International clinical psychopharmacology, 28(6), 287-296 (2013-07-23)

Side effects are among the most frequent reasons preventing patients from taking their medication. Although the management of side effects is an important issue in clinical practice, particularly in patients with physical comorbidities, research on clinical management of side effects

Using lithium as a neuroprotective agent in patients with cancer.

Mustafa Khasraw et al.

BMC medicine, 10, 131-131 (2012-11-06)

Neurocognitive impairment is being increasingly recognized as an important issue in patients with cancer who develop cognitive difficulties either as part of direct or indirect involvement of the nervous system or as a consequence of either chemotherapy-related or radiotherapy-related complications.

Lithium: still a major option in the management of bipolar disorder.

Rasmus W Licht

CNS neuroscience & therapeutics, 18(3), 219-226 (2011-11-11)

Still after more than 50 years, lithium is a major treatment of bipolar disorder, even though it has not been promoted by the pharmaceutical industry over the last decades. In recent years the evidence base on lithium for bipolar disorder

View All Related Papers

Global Trade Item Number

SKU	GTIN
GF62158596-2EA	04061829521462
GF62158596-3EA	04061829592653
GF62158596-1EA	04061825410401
GF62158596-5EA	04061829570668
GF62158596-4EA	04061829592660